Waterdrop (ADR) (WDH)
Connects insurance brokerage, medical crowdfunding, and clinical-trial patient recruitment in China.
$1.04
After-hours close−0.01 (−0.95%)
At close$1.05(−0.94%)
In millions of USD, except per-share figures · converted from CNY at the latest rate
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 103 | 99 | 105 | 101 | 105 | 103 | 113 | 125 | 146 | 208 | 185 | 217 |
| Cost of revenue | 47 | 104 | 50 | 48 | 51 | 93 | 56 | 62 | 71 | 100 | 72 | 80 |
| Gross profit | 56 | −5 | 56 | 53 | 54 | 10 | 57 | 63 | 75 | 108 | 112 | 136 |
| 56 | −9 | 49 | 46 | 50 | 2 | 45 | 48 | 58 | 96 | 100 | 120 | |
| Research & development | 11 | 9 | 8 | 8 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 10 |
| 45 | −18 | 41 | 38 | 42 | −6 | 37 | 41 | 49 | 86 | 91 | 109 | |
| Selling & marketing | 28 | −32 | 27 | 24 | 26 | −17 | 26 | 30 | 36 | 0 | 0 | 0 |
| General & administrative | 17 | 14 | 13 | 14 | 17 | 11 | 11 | 11 | 13 | 0 | 0 | 0 |
| Operating income | 0 | 4 | 7 | 8 | 4 | 8 | 11 | 15 | 17 | 12 | 12 | 17 |
| 6 | 7 | 6 | 6 | 9 | 6 | 6 | 6 | 8 | 5 | 4 | 6 | |
| Interest income | 5 | 5 | 6 | 6 | 5 | 5 | 5 | 4 | 6 | 5 | 4 | 4 |
| Income before tax | 5 | 11 | 13 | 14 | 13 | 14 | 18 | 21 | 25 | 18 | 16 | 22 |
| Income tax expense | 0 | 2 | 1 | 1 | −1 | 0 | 2 | 0 | 1 | −6 | 1 | 3 |
| Net income from continuing operations | 5 | 8 | 12 | 13 | 14 | 14 | 16 | 21 | 24 | 24 | 15 | 19 |
| Net income | 5 | 9 | 12 | 13 | 14 | 16 | 16 | 21 | 24 | 24 | 15 | 19 |
| EPS, basic | $0.01 | $0.02 | $0.03 | $0.04 | $0.04 | $0.04 | $0.04 | $0.06 | $0.07 | $0.66 | $0.40 | $0.52 |
| EPS, diluted | $0.01 | $0.02 | $0.03 | $0.04 | $0.04 | $0.04 | $0.04 | $0.06 | $0.06 | $0.58 | $0.39 | $0.51 |
| Weighted average shares, basic | 372 | 370 | 370 | 373 | 362 | 362 | 362 | 361 | 362 | 36 | 36 | 36 |
| Weighted average shares, diluted | 381 | 376 | 376 | 373 | 369 | 370 | 371 | 371 | 372 | 37 | 37 | 37 |
| EBITDA | 0 | 4 | 7 | 8 | 4 | 8 | 11 | 15 | 17 | 12 | 12 | 17 |
| Depreciation & amortization | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | 0 | 4 | 7 | 8 | 4 | 8 | 11 | 15 | 17 | 12 | 12 | 17 |